A double-blind, placebo-controlled, crossover study of sildenafil in patients with chronic obstructive pulmonary disease

Trial Profile

A double-blind, placebo-controlled, crossover study of sildenafil in patients with chronic obstructive pulmonary disease

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Jun 2012

At a glance

  • Drugs Sildenafil (Primary)
  • Indications Chronic obstructive pulmonary disease; Emphysema
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Jun 2012 Results published in COPD: the Journal of Chronic Obstructive Pulmonary Disease.
    • 18 May 2012 Last checked against ClinicalTrials.gov record.
    • 28 Sep 2011 Primary endpoint 'Maximal-oxygen-consumption' has not been met, according to the results reported at ERS 2011.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top